30mg tablets of Shire Plc’s Adderall XR are arranged in a Cambridge, Massachusetts pharmacy on Tuesday, August 15, 2006. Shire Plc shares rose after the company settled a patent lawsuit with Barr Pharmaceuticals Inc., protecting Shire’s best-selling Adderall XR hyperactivity drug from cheaper rival copies until 2009. Photographer: JB Reed/Bloomberg News. ORG XMIT: BUDGET 8/15/06